DOI QR코드

DOI QR Code

Warfarin-Induced Eosinophilic Pleural Effusion

  • Jo, Yong-Min (Division of Cardiology, Department of Internal Medicine, Dong-A University College of Medicine) ;
  • Park, Tae-Ho (Division of Cardiology, Department of Internal Medicine, Dong-A University College of Medicine) ;
  • Jeong, Il-Hwan (Division of Cardiology, Department of Internal Medicine, Dong-A University College of Medicine) ;
  • Kim, Hyun-Jeong (Division of Cardiology, Department of Internal Medicine, Dong-A University College of Medicine) ;
  • Ahn, Ji-Hye (Division of Cardiology, Department of Internal Medicine, Dong-A University College of Medicine) ;
  • Kim, Woo-Jae (Division of Cardiology, Department of Internal Medicine, Dong-A University College of Medicine) ;
  • Cho, Young-Rak (Division of Cardiology, Department of Internal Medicine, Dong-A University College of Medicine) ;
  • Baek, Hee-Kyung (Division of Cardiology, Department of Internal Medicine, Dong-A University College of Medicine) ;
  • Kim, Moo-Hyun (Division of Cardiology, Department of Internal Medicine, Dong-A University College of Medicine) ;
  • Kim, Young-Dae (Division of Cardiology, Department of Internal Medicine, Dong-A University College of Medicine)
  • Published : 2011.02.28

Abstract

A 29-year-old man suffering from dyspnea and eosinophilic pleural effusion after being on warfarin for pulmonary thromboembolism for a period of one month, was readmitted to our hospital. Etiology of pleural effusion other than warfarin was excluded. To the best of our knowledge, this is the first case of warfarin-induced pleural effusion reported in Korea.

Keywords

References

  1. Cooper JA Jr, White DA, Matthay RA. Drug-induced pulmonary disease (part I & II). Am Rev Respir Dis 1986;133:488-505.
  2. Moufarrege G, Frank E, Carstens DD. Eosinophilic exudative pleural effusion after initiation of tizanidine treatment: a case report. Pain Med 2003;4:85-90. https://doi.org/10.1046/j.1526-4637.2003.03003.x
  3. Anshelevich IV, Svistunova AA. Eosinophilic exudative pleurisy as a manifestation of drug allergy. Ter Arkh 1986;58:142-3.
  4. Huggins JT, Sahn SA. Drug-induced pleural disease. Clin Chest Med 2004;25:141-53. https://doi.org/10.1016/S0272-5231(03)00125-4
  5. You SH, Hong SJ, Ahn CM, Lim DS. Eosinophilic endomyocarditis combined with pericardial and pleural effusion. Korean Circ J 2009; 39:545-7. https://doi.org/10.4070/kcj.2009.39.12.545
  6. Krenke R, Nasilowski J, Korczynski P, et al. Incidence and aetiology of eosinophilic pleural effusion. Eur Respir J 2009;34:1111-7. https://doi.org/10.1183/09031936.00197708
  7. Martinez-Garcia MA, Cases-Viedma E, Cordero-Rodriguez PJ, et al. Diagnostic utility of eosinophils in the pleural fluid. Eur Respir J 2000;15:166-9. https://doi.org/10.1183/09031936.00.15116600
  8. Kalomenidis I, Light RW. Eosinophilic pleural effusions. Curr Opin Pulm Med 2003;9:254-60. https://doi.org/10.1097/00063198-200307000-00002
  9. Stein PD, Henry JW. Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes. Chest 1997;112:974-9. https://doi.org/10.1378/chest.112.4.974
  10. Simon HB, Daggett WM, DeSanctis RW. Hemothorax as a complication of anticoagulant therapy in the presence of pulmonary infarction. JAMA 1969;208:1830-4. https://doi.org/10.1001/jama.1969.03160100020005
  11. Kuwahara T, Hamada M, Inoue Y, Aono S, Hiwada K. Warfarin-induced eosinophilic pleurisy. Intern Med 1995;34:794-6. https://doi.org/10.2169/internalmedicine.34.794
  12. Mo EK, Oh YM, Jung MP, et al. A prospective study on the diagnostic value of adenosine deaminase activity in tuberculous pleural effusion. Korean J Med 1995;48:625-33.

Cited by

  1. Effects of subacute oral warfarin administration on peripheral blood granulocytes in rats vol.50, pp.5, 2011, https://doi.org/10.1016/j.fct.2012.01.049
  2. Oral warfarin affects peripheral blood leukocyte IL-6 and TNFα production in rats vol.10, pp.1, 2011, https://doi.org/10.3109/1547691x.2012.684159
  3. Strain differences in intestinal toxicity of warfarin in rats vol.48, pp.None, 2011, https://doi.org/10.1016/j.etap.2016.10.019
  4. Oral warfarin affects some aspects of systemic immunomodulation with topical dinitrochlorobenzene (DNCB) in rats vol.37, pp.1, 2011, https://doi.org/10.1080/15569527.2017.1328690
  5. Mesalamine-induced eosinophilic pleural effusion vol.13, pp.4, 2011, https://doi.org/10.1136/bcr-2019-233886